Biofidelity’s proprietary reagents utilize the breakthrough ASPYRE technology Biofidelity’s proprietary reagents utilize the breakthrough ASPYRE technology
 

Biofidelity’s proprietary reagents utilize the breakthrough ASPYRE technology

 

Biofidelity is harnessing the ASPYRE technology to develop genetic panels that are:

 
 

Fast & Simple

Actionable mutations in under 4 hours on existing real-time PCR systems

Ultra-sensitive

Detecting tumor markers to 0.1% allele fraction

Multiplexed

Up to 1000's of mutations and fusions in a single test

Comprehensive

Simultaneous DNA & RNA analysis in a single run

 

Want to know more?

Contact us

Identi-Lung

COMING SOON: Identi-Lung

Comprehensive coverage of guideline recommended markers

View product specification
 

ASPYRE - New Products and Applications

 
 

Our efficient development process enables the rapid development of future assays

A pipeline of panels covering a range of cancers:

  • Colorectal
  • Melanoma
  • Head & neck
  • Liver & kidney
  • Breast

Follow us for regular updates

Opportunities for partnership in assay & panel development

  • Single/multi gene panels covering DNA & RNA
  • Resistance monitoring
  • MRD
  • Direct detection of methylation markers
  • Early detection of disease
  • Prenatal diagnostics
  • Infectious disease
  • Organ transplant monitoring

Contact for development opportunities